Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > Levered Free Cash Flow (FCF)

Ampio Pharmaceuticals Levered Free Cash Flow (FCF) Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2018.
  • Ampio Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-3m a 68.32% decrease of -2m year over year
  • Ampio Pharmaceuticals Levered Free Cash Flow (FCF) for the last 12 months ending September 09, 2018 was $-8m a 28.39% decrease of -2m year over year
  • Ampio Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2017 was $-6m a 130.91% decrease of -7m from 2016
  • Ampio Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2016 was $2m a 1,249.05% increase of 21m from 2015
  • Ampio Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2015 was $-20m a -2.77% increase of 1m from 2014
Other Cash Flow Metrics:
  • Ampio Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-3m a 19.89% decrease of -1m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE Levered Free Cash Flow (FCF) Data

09/2018$-3m
06/2018$-2m
03/2018$-2m
12/2017$-1m
09/2017$-2m
06/2017$-1m
03/2017$-2m
12/2016$-1m
09/2016$-1m
06/2016$-3m

Annual AMPE Levered Free Cash Flow (FCF) Data

2017$-6m
2016$2m
2015$-20m
2014$-20m
2013$-12m
2012$-5m
2011$-5m
2010$0m